logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Liver Cirrhosis

    FiltersReset Filters
    13 results

    • aminocaproic acid

      (Aminocaproic acid)
      BPI LABS LLC
      Usage: Aminocaproic acid oral solution is indicated for enhancing hemostasis in cases of fibrinolysis-related bleeding, particularly in surgical complications, hematological disorders, abruptio placentae, hepatic cirrhosis, and certain cancers. It also addresses excessive urinary tract bleeding due to surgical or nonsurgical conditions. Emergency measures may be necessary.

    • aminocaproic acid

      (AMINOCAPROIC ACID)
      Biocon Pharma Inc.
      Usage: Aminocaproic acid is indicated for enhancing hemostasis in scenarios where fibrinolysis causes bleeding, particularly after heart surgery, in hematological disorders, hepatic cirrhosis, and related neoplastic diseases. It is also used for excessive urinary tract bleeding following surgical or nonsurgical interventions.

    • aminocaproic acid

      (AMINOCAPROIC ACID)
      Carnegie Pharmaceuticals, LLC
      Usage: Aminocaproic acid enhances hemostasis in cases of fibrinolysis-related bleeding, particularly during heart surgery, in hematological disorders, and during severe conditions like abruptio placentae and certain cancers. It also addresses excessive urinary tract bleeding associated with surgical or nonsurgical hematuria.

    • chlorthalidone

      (Chlorthalidone)
      Chartwell RX, LLC
      Usage: Chlorthalidone is indicated for managing hypertension, either alone or with other antihypertensive agents, and as adjunctive therapy for edema related to congestive heart failure, hepatic cirrhosis, corticosteroid and estrogen therapy, and various renal dysfunctions, including nephrotic syndrome and chronic renal failure.

    • chlorthalidone

      (Chlorthalidone)
      Nivagen Pharmaceuticals, INC.
      Usage: Chlorthalidone is indicated for managing hypertension, either alone or with other antihypertensives, and as adjunctive therapy for edema related to congestive heart failure, hepatic cirrhosis, and certain renal dysfunctions. Its use in pregnancy is limited to pathologic edema, as routine use is inappropriate.

    • ethacrynate sodium

      (ETHACRYNATE SODIUM)
      Leading Pharma, LLC
      Usage: Ethacrynic acid is indicated for treating edema in conditions such as congestive heart failure, liver cirrhosis, and renal disease. It is also used for short-term management of malignancy-related ascites, idiopathic edema, and pediatric patients with specific heart conditions, particularly when rapid diuresis is needed.

    • ethacrynate sodium

      (ethacrynate sodium)
      Par Pharmaceutical, Inc.
      Usage: Ethacrynate sodium is indicated for treating edema associated with congestive heart failure, liver cirrhosis, renal disease, malignancy-related ascites, idiopathic edema, lymphedema, and hospitalized pediatric patients with congenital heart disease. It is also used intravenously for rapid diuresis in acute conditions or when oral administration is impractical.

    • ethacrynic acid

      (Ethacrynic acid)
      TRUPHARMA LLC
      Usage: Ethacrynic Acid Tablets are indicated for treating edema requiring potent diuresis, associated with conditions like congestive heart failure, liver cirrhosis, and renal disease. They are also used for managing ascites, idiopathic edema, and lymphedema, and for hospitalized pediatric patients with specific conditions. Intravenous forms are for rapid diuresis.

    • furosemide

      (Furosemide)
      Meitheal Pharmaceuticals Inc.
      Usage: Furosemide Injection is indicated for treating edema due to congestive heart failure, cirrhosis, and renal disease in adults and children. It is also used adjunctively in acute pulmonary edema when rapid diuresis is needed, especially when oral administration is not feasible.

    • furosemide

      (Furosemide)
      Eugia US LLC
      Usage: Furosemide Injection is indicated for parenteral therapy in patients who cannot take oral medications, especially for treating edema related to congestive heart failure, liver cirrhosis, and renal disease. It's also used as adjunctive therapy in acute pulmonary edema when rapid diuresis is needed.